BMY Financial Facts
Net Sales: 4.92BDividends declared per common share: 0.38
See Full Income Statement
Accounts payable: 1.41B
U.S. and foreign income taxes payable: 312M
See Full Balance Sheet
Bristol-Myers Squibb Company (BMY) Earnings
|
Expand Research on BMY
| Next EPS Date | 4/25/24 | EPS Growth Rate | -21.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +2.8% | Revenue Growth Rate | +1.5% |
| Average % Move 1-Wk after EPS | -3.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24  |
Q124 | N/A | $1.61 | N/A | N/A | $11.47B | = | N/A | N/A | ||
| 2/2/24 | Q423 | $1.70 | $1.60 | +$0.10 | $11.48B | $11.22B | = |  | | Details | |
| 10/26/23 | Q323 | $2.00 | $1.78 | +$0.22 | $11B | $10.98B | = | | | Details | |
| 7/27/23 | Q223 | $1.75 | $1.98 | -$0.23 | $11.2B | $11.81B | = | | | Details | |
| 4/27/23 | Q123 | $2.05 | $1.97 | +$0.08 | $11.3B | $11.49B | = | | | Details | |
| 2/2/23 | Q422 | $1.82 | $1.73 | +$0.09 | $11.4B | $11.21B | = | | | Details | |
| 10/25/22 | Q322 | $1.99 | $0.00 | +$1.99 | $11.22B | N/A | = | | | Details | |
| 10/26/22 | Q322 | $1.99 | $1.82 | +$0.17 | $11.22B | $11.15B | = | | | Details |
